A Clinical Trial of TQH3906 Capsules in Adult Patients With Moderate to Severe Plaque Psoriasis

Conditions

• Psoriasis

Interventions

• DRUG: TQH3906 capsules
• DRUG: Deucravacitinib tablets 6 mg
• DRUG: TQH3906 Capsules placebo
• DRUG: Deucravacitinib tablets placebo

Sponsor

Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.